Regulatory Roundup: ISPE to Hold Risk-MaPP 2010 Conference

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Calquence (acalabrutinib) plus bendamustine and rituximab reduced risk for disease progression or death by 27% compared with the current standard of care, according to a phase III trial.

Scientific, economic, and practical factors should be considered when choosing between the frozen state and lyophilization.